These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 23536610)

  • 21. Promising strategies to minimize reperfusion injury in STEMI.
    Bulluck H; Yellon RL; Yellon DM
    Minerva Cardioangiol; 2016 Jun; 64(3):284-94. PubMed ID: 26859232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.
    Atar D; Arheden H; Berdeaux A; Bonnet JL; Carlsson M; Clemmensen P; Cuvier V; Danchin N; Dubois-Randé JL; Engblom H; Erlinge D; Firat H; Halvorsen S; Hansen HS; Hauke W; Heiberg E; Koul S; Larsen AI; Le Corvoisier P; Nordrehaug JE; Paganelli F; Pruss RM; Rousseau H; Schaller S; Sonou G; Tuseth V; Veys J; Vicaut E; Jensen SE
    Eur Heart J; 2015 Jan; 36(2):112-9. PubMed ID: 25179768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reperfusion in STEMI patients: still a role for cardioprotection?
    Ottani F; Limbruno U; Latini R; Misuraca L; Galvani M
    Minerva Cardioangiol; 2018 Aug; 66(4):452-463. PubMed ID: 29589674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Endogenous cardioprotective mechanisms - what is it about and how does it work?].
    Beręsewicz A
    Kardiol Pol; 2011; 69 Suppl 3():59-66. PubMed ID: 22125205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):223-32. PubMed ID: 21821520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pacing post-conditioning during revascularization after AMI.
    Waltenberger J; Gelissen M; Bekkers SC; Vainer J; van Ommen V; Eerens F; Ruiters A; Holthuijsen A; Cuesta P; Strauven R; Mokelke E; Gorgels A; Prinzen FW
    JACC Cardiovasc Imaging; 2014 Jun; 7(6):620-6. PubMed ID: 24925330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of the 'MITOCARE' Study: a phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
    MITOCARE Study Group
    Cardiology; 2012; 123(4):201-7. PubMed ID: 23202613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-treatment of a single high-dose of atorvastatin provided cardioprotection in different ischaemia/reperfusion models via activating mitochondrial KATP channel.
    Zhao Z; Cui W; Zhang H; Gao H; Li X; Wang Y; Hu H; Li B
    Eur J Pharmacol; 2015 Mar; 751():89-98. PubMed ID: 25641746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
    Quintana M; Kahan T; Hjemdahl P
    Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remote Ischemic Postconditioning (RIPC) of the Upper Arm Results in Protection from Cardiac Ischemia-Reperfusion Injury Following Primary Percutaneous Coronary Intervention (PCI) for Acute ST-Segment Elevation Myocardial Infarction (STEMI).
    Cao B; Wang H; Zhang C; Xia M; Yang X
    Med Sci Monit; 2018 Feb; 24():1017-1026. PubMed ID: 29456238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
    García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
    Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials.
    Gerczuk PZ; Kloner RA
    J Am Coll Cardiol; 2012 Mar; 59(11):969-78. PubMed ID: 22402067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting mitochondria for cardioprotection: examining the benefit for patients.
    Dongworth RK; Hall AR; Burke N; Hausenloy DJ
    Future Cardiol; 2014 Mar; 10(2):255-72. PubMed ID: 24762253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
    Hausenloy DJ; Garcia-Dorado D; Bøtker HE; Davidson SM; Downey J; Engel FB; Jennings R; Lecour S; Leor J; Madonna R; Ovize M; Perrino C; Prunier F; Schulz R; Sluijter JPG; Van Laake LW; Vinten-Johansen J; Yellon DM; Ytrehus K; Heusch G; Ferdinandy P
    Cardiovasc Res; 2017 May; 113(6):564-585. PubMed ID: 28453734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischaemic conditioning and reperfusion injury.
    Hausenloy DJ; Yellon DM
    Nat Rev Cardiol; 2016 Apr; 13(4):193-209. PubMed ID: 26843289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.